Panicolytic-like effect of BDNF in the rat dorsal periaqueductal grey matter: The role of 5-HT and GABA

International Journal of Neuropsychopharmacology

Volumn 13, Issue 5, 2010, Pages 573-582

  Casarotto, Plnio Cabrera ^a   De Bortoli, Valquiria Camin ^a   De Aguiar Corra, Fernando Morgan ^a   Moraes Resstel, Leonardo Barbosa ^a   Zangrossi, Hélio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

BDNF; Dorsal periaqueductal grey matter; GABA; Panic; Serotonin

Indexed keywords

4 AMINOBUTYRIC ACID; ANTIDEPRESSANT AGENT; ANTIPANIC AGENT; BICUCULLINE; BRAIN DERIVED NEUROTROPHIC FACTOR; K 252A; KETANSERIN; MESSENGER RNA; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NEUROTROPHIN; PROTEIN; RECEPTOR; SEROTONIN; TROPOMYOSIN RELATED KINASE B RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG MECHANISM; ELECTRIC CURRENT; ESCAPE BEHAVIOR; GABAERGIC TRANSMISSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PANIC; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; GAMMA-AMINOBUTYRIC ACID; HUMANS; INJECTIONS, INTRAVENTRICULAR; MALE; PANIC DISORDER; PERIAQUEDUCTAL GRAY; RATS; RATS, WISTAR; RECEPTOR, TRKB; RECEPTORS, SEROTONIN; RECOMBINANT PROTEINS; SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 77953538200     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S146114570999112X     Document Type: Article

References (44)

1. Amano K, Tanikawa T, Iseki H, Kawabatake H, et al. (1978). Single neuron analysis of the human midbrain tegmentum. Rostral mecencephalic reticulotomy for pain relief. Applied Neurophysiology 41, 66-78.
2. Bandler R, Carrive P, Zhang SP (1991). Integration of somatic and autonomic reactions within the midbrain periaqueductal grey: viscerotopic, somatotopic and functional organization. Progress in Brain Research 87, 269-305.
3. Bariohay B, Tardivel C, Pio J, Jean A, et al. (2008). BDNF-TrkB signaling interacts with the GABAergic system to inhibit rhythmic swallowing in the rat. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 295, R1050-1059.
4. Bueno CH, Zangrossi Jr. H, Nogueira RL, Soares VP, et al. (2005). Panicolytic-like effect induced by the stimulation of GABAA and GABAB receptors in the dorsal periaqueductal grey of rats. European Journal of Pharmacology 516, 239-246.
5. Coimbra NC, De Oliveira R, Freitas RL, Ribeiro SJ, et al. (2006). Neuroanatomical approaches of the tectum-reticular pathways and immunohistochemical evidence for serotonin-positive perikarya on neuronal substrates of the superior colliculus and periaqueductal gray matter involved in the elaboration of the defensive behavior and fear-induced analgesia. Experimental Neurology 197, 93-112.
6. Conner JM, Lauterborn JC, Yan Q, Gall CM, et al. (1997). Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. Journal of Neuroscience 17, 2295-2313.
7. de Bortoli VC, Nogueira RL, Zangrossi Jr. H (2006). Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray. Psychopharmacology 183, 422-428.
8. de Bortoli VC, Nogueira RL, Zangrossi Jr. H (2008). Alprazolam potentiates the antiaversive effect induced by the activation of 5-HT(1A) and 5-HT (2A) receptors in the rat dorsal periaqueductal gray. Psychopharmacology 198, 341-349.
9. de Paula Soares V, Zangrossi Jr. H (2004). Involvement of 5-HT1A and 5-HT2 receptors of the dorsal periaqueductal gray in the regulation of the defensive behaviors generated by the elevated T-maze. Brain Research Bulletin 64, 181-188.
10. Deltheil T, Tanaka K, Reperant C, Hen R, et al. (2009). Synergistic neurochemical and behavioural effects of acute intrahippocampal injection of brain-derived neurotrophic factor and antidepressants in adult mice. International Journal of Neuropsychopharmacology 12, 905-915.
11. Graeff FG (1990). Brain defense system and anxiety. In: Burrows GD, Roth M, Noyes JRR (Eds), Handbook of Anxiety: The Neurobiology of Anxiety (pp. 301-354) Amsterdam: Elsevier Science Publishers.
12. Graeff FG, Silveira MCL, Nogueira RL, Audi EA, et al. (1993). Role of the amygdala and periaqueductal gray in anxiety and panic. Brazilian Journal of Medical and Biological Research 58, 123-131.
13. Graeff FG, Zangrossi Jr. H (2002). Animal models of anxiety disorders. In: D'haenen H, Den Boer JA, Westenberg HG, Willner P (Eds), Textbook of Biological Psychiatry (pp. 879-893), London: Wiley.
14. Hilborn MD, Vaillancourt RR, Rane SG (1998). Growth factor receptor tyrosine kinases acutely regulate neuronal sodium channels through the src signaling pathway. Journal of Neuroscience 18, 590-600.
15. Jacob CA, Cabral AHCL, Almeida LP, Magierek V, et al. (2002). Chronic imipramine enhances 5-HT1A and 5-HT2 receptors-mediated inhibition of panic-like behavior in the rat dorsal periaqueductal gray. Pharmacology, Biochemistry and Behavior 72, 761-766.
16. Jenck F, Moreau JL, Martin JR (1995). Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity. Psychiatry Research 57, 181-191.
17. Jovanovic JN, Czernik AJ, Fienberg AA, Greengard P, et al. (2000). Synapsins as mediators of BDNF-enhanced neurotransmitter release. Nature Neuroscience 3, 323-329.
18. Jovanovic JN, Thomas P, Kittler JT, Smart TG, et al. (2004). Brain-derived neurotrophic factor modulates fast synaptic inhibition by regulating GABA(A) receptor phosphorylation, activity, and cell-surface stability. Journal of Neuroscience 24, 522-530.
19. Kobayashi K, Shimizu E, Hashimoto K, Mitsumori M, et al. (2005). Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group cognitive behavioral therapy. Progress in NeuroPsychopharmacology and Biological Psychiatry 29, 658-663.
20. Krieger JE, Graeff FG (1985). Defensive behavior and hypertension induced by glutamate in the midbrain central gray of the rat. Brazilian Journal of Medical and Biological Research 18, 61-67.
21. Lovick TA, Parry DM, Stezhka VV, Lumb BM (2000). Serotonergic transmission in the periaqueductal gray matter in relation to aversive behaviour: morphological evidence for direct modulatory effects on identified output neurons. Neuroscience 95, 763-772.
22. Maron E, Toru I, Maemets K, Sepp S, et al. (2009). CCK-4-induced anxiety but not panic is associated with serum brain-derived neurotrophic factor in healthy subjects. Journal of Psychopharmacology 23, 460-464.
23. Martinowich K, Manji H, Lu B (2007). New insights into BDNF function in depression and anxiety. Nature Neuroscience 10, 1089-1093.
24. Mongeau R, Marsden CA (1997). Effect of imipramine treatments on the 5-HT1A-receptor-mediated inhibition of panic-like behaviours in rats. Psychopharmacology 131, 321-328.
25. Nashold BS, Wilson WP, Slaughter DG (1969). Sensations evoked by stimulation in the midbrain of man. Journal of Neurosurgery 30, 14-24.
26. Nogueira RL, Graeff FG (1995). Role of 5-HT receptor subtypes in the modulation of dorsal periaqueductal gray generated aversion. Pharmacology, Biochemistry and Behavior 52, 1-6.
27. Numan S, Seroogy KB (1999). Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: a double-label in situ hybridization study. Journal of Comparative Neurology 403, 295-308.
28. Olds ME, Olds J (1962). Approach-escape interactions in rat brain. American Journal of Physiology 203, 803-810.
29. Pandey SC, Zhang H, Roy A, Misra K (2006). Central and medial amygdaloid brain-derived neurotrophic factor signaling plays a critical role in alcohol-drinking and anxiety-like behaviors. Journal of Neuroscience 26, 8320-8331.
30. Paxinos G, Watson C (2007). The Rat Brain in Stereotaxic Coordinates. London: Academic Press.
31. 2+ oscillations in cultured hippocampal neurons. Brain Research 778, 318-328.
32. Schenberg LC, Bittencourt AS, Sudre EC, Vargas LC (2001). Modeling panic attacks. Neuroscience and Biobehavioral Reviews 25, 647-659.
33. Schenberg LC, Vasquez EC, Costa M (1993). Cardiac baroreflex dynamics during the defense reaction in freely moving rats. Brain Research 621, 50-58.
34. Schütz MT, de Aguiar JC, Graeff FG (1985). Anti-aversive role of serotonin in the dorsal periaqueductal gray matter. Psychopharmacology 85, 340-345.
35. Shirayama Y, Chen AC, Nakagawa S, Russell DS, et al. (2002). Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. Journal of Neuroscience 22, 3251-3261.
36. Siuciak JA, Altar CA, Wiegand SJ, Lindsay RM (1994). Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3. Brain Research 633, 326-330.
37. Siuciak JA, Boylan C, Fritsche M, Altar CA, et al. (1996). BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration. Brain Research 710, 11-20.
38. Siuciak JA, Clark MS, Rind HB, Whittemore SR, et al. (1998). BDNF induction of tryptophan hydroxylase mRNA levels in the rat brain. Journal of Neuroscience Research 52, 149-158.
39. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM (1997). Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacology, Biochemistry and Behavior 56, 131-137.
40. Vaz SH, Cristovao-Ferreira S, Ribeiro JA, Sebastiao AM (2008). Brain-derived neurotrophic factor inhibits GABA uptake by the rat hippocampal nerve terminals. Brain Research 1219, 19-25.
41. Wang YT, Bieger D (1991). Role of solitarial GABAergic mechanisms in control of swallowing. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 261, 639-646.
42. Yan Q, Radeke MJ, Matheson CR, Talvenheimo J, et al. (1997). Immunocytochemical localization of TrkB in the central nervous system of the adult rat. Journal of Comparative Neurology 378, 135-157. (Pubitemid 27057536)
43. Zanoveli JM, Nogueira RL, Zangrossi Jr. H (2005). Chronic imipramine treatment sensitizes 5-HT1A and 5-HT2A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety. Behavioural Pharmacology 16, 543-552.
44. Zanoveli JM, Nogueira RL, Zangrossi Jr. H (2007). Enhanced reactivity of 5-HT1A receptors in the rat dorsal periaqueductal gray matter after chronic treatment with fluoxetine and sertraline: evidence from the elevated T-maze. Neuropharmacology 52, 1188-1195.